...
首页> 外文期刊>Brachytherapy >Rebuttal to Drs. Good, Lalondrelle, and Blake
【24h】

Rebuttal to Drs. Good, Lalondrelle, and Blake

机译:反驳博士。 Good,Lalondrelle和Blake

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The arguments brought forward by Drs. Good, Lalon-drelle, and Blake in favor of parametrial boost (PMB) by external beam radiotherapy (EBRT) brilliantly display the many dilemmas facing the proponents of this technique. Unfortunately, solutions to the problems are not provided. A vivid anatomical description of the parametrium as an open landscape ready to be swept by the attacking malignant cells breaking through the cervix is used to promote the use of EBRT to boost the parametrium to a higher EBRT dose than used to "at-risk nodal areas." However, we are still left in the dark with regard to the central questions of when, where, and how much. Is PMB to be delivered routinely by EBRT to all patients with breach of the cervical stroma? Should we apply PMB unilaterally or bilaterally and what total dose of EBRT (50 or 62 Gy) is necessary to control microscopic disease in the parametrium?
机译:博士提出的论点。 Good,Lalon-drelle和Blake赞成采用外部束放射疗法(EBRT)进行子宫旁肌强化(PMB),这很好地展示了该技术支持者面临的许多难题。不幸的是,没有提供解决问题的方法。对子宫旁膜的生动解剖学描述是一个开放的景观,准备好被侵袭子宫颈的恶性细胞冲刷,用于促进EBRT的使用,从而使子宫旁膜的EBRT剂量比用于“有风险的淋巴结区域”的剂量高。 。”但是,关于何时,何地以及多少的核心问题,我们仍然一无所知。是否会由EBRT常规将PMB运送给所有宫颈口裂的患者?我们应该单侧或双侧应用PMB,并且需要多少总EBRT剂量(50或62 Gy)来控制子宫内膜炎?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号